// App-Quantinova.ai

OP0148 : MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS

Researchers

Presenter

  • A. Bettiol

Principal Investigators

  • F. Alberici

  • C. Agostini

  • C. Baldini

  • E. Bozzolo

  • P. Cameli

  • N. Crimi

  • S. Del Giacco

  • A. Egan

  • G. Espigol-Frigole

  • M. Felicetti

  • M. Folci

  • P. Fraticelli

  • M. Govoni

  • A. Kernder

  • C. Lombardi

  • G. Lopalco

  • C. Lunardi

  • A. J. Mohammad

  • F. Moosig

  • S. Negrini

  • T. Neumann

  • P. Novikov

  • G. Paolazzi

  • P. Parronchi

  • L. Quartuccio

  • V. Racanelli

  • C. Salvarani

  • M. Samson

  • J. Schroeder

  • S. Sciascia

  • R. A. Sinico

  • B. Terrier

  • P. Toniati

  • D. Prisco

  • A. Vaglio

  • G. Emmi

Medical Centers

  • University of Florence, Florence, Italy

  • University of Brescia, Brescia, Italy

  • University of Padua, Treviso, Italy

  • University of Pavia, Pavia, Italy

  • University of Milan, Milan, Italy

  • University Hospital of Siena, Siena, Italy

  • University of Catania, Catania, Italy

  • University Hospital of Cagliari, Cagliari, Italy

  • University of Cambridge, Cambridge, United Kingdom

  • Universitat de Barcelona, Barcelona, Spain

  • University of Pavia, Pavia, Italy

  • Universita Ancona, Ancona, Italy

  • University of Ferrara, Ferrara, Italy

  • University Hospital, Duesseldorf, Germany

  • University of Bari, Bari, Italy

  • University of Verona, Verona, Italy

  • Univ. of Lund, Lund, Sweden.

  • University Hospital of Muenster, Muenster, Germany

  • University of Genoa, Genoa, Italy

  • University of St. Gallen, St. Gallen, Switzerland

  • University of Moscow, Moscow, Russian Federation

  • University of Trento, Trento, Italy

  • University Hospital, Udine, Italy

  • University of Reggio Emilia, Reggio Emilia, Italy

  • University Hospital, Dijon, France

  • Ospedale Niguarda, Milano, Italy

  • University of Turin, Turin, Italy

  • University Paris-Sud, Paris, France

Locations

  • Italy

  • United Kingdom

  • Spain

  • Germany

  • Sweden

  • Switzerland

  • Russia

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved